title: Hepatic allograft rejection under quadruple immunosuppressive regimen with cyclosporine A in liver transplantation: incidence of viral and fungal infection.
authors.affiliation: Liver Transplant Unit, Universidad de Barcelona, Spain.
authors.forename: J
authors.initials: J
authors.lastname: Fabregat
authors.forename: R
authors.initials: R
authors.lastname: Fradera
authors.forename: J
authors.initials: J
authors.lastname: Figueras
authors.forename: A
authors.initials: A
authors.lastname: Rafecas
authors.forename: J
authors.initials: J
authors.lastname: Torras
authors.forename: J
authors.initials: J
authors.lastname: Martinez LaCasa
authors.forename: C
authors.initials: C
authors.lastname: Baliellas
authors.forename: L
authors.initials: L
authors.lastname: Casais
authors.forename: E
authors.initials: E
authors.lastname: Jaurrieta
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D016572:Cyclosporine / Q000627:therapeutic use*; D003586:Cytomegalovirus Infections / Q000175:diagnosis / Q000453:epidemiology*; D004359:Drug Therapy, Combination; D005260:Female; D006084:Graft Rejection / Q000453:epidemiology / Q000276:immunology*; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods*; D015994:Incidence; D016031:Liver Transplantation / Q000276:immunology*; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D016853:Muromonab-CD3 / Q000627:therapeutic use; D009181:Mycoses / Q000453:epidemiology* / Q000517:prevention & control; D009761:Nystatin / Q000627:therapeutic use; D011446:Prospective Studies; D014184:Transplantation, Homologous
chemical_list: D000961:Antilymphocyte Serum; D016853:Muromonab-CD3; D009761:Nystatin; D016572:Cyclosporine; D008775:Methylprednisolone